DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

56.13 -1.03 (-1.80%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ISIS $56.13 -1.80%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $57.10
Previous Close $57.16
Daily Range $55.77 - $57.16
52-Week Range $27.37 - $77.80
Market Cap $6.7B
P/E Ratio -280.65
Dividend (Yield) $0.00 (0.0%)
Volume 1,521,862
Average Daily Volume 2,524,873
Current FY EPS -$0.26

Sector

Healthcare

Industry

Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website: http://www.isispharm.com/

News & Commentary

3 Biotech Stocks to Buy As the Greek Tragedy Unfolds

Exelixis, Enanta Pharmaceuticals, and Isis Pharmaceuticals are three names in biotech I'm closely watching in case they fall as a result of the financial crisis in Greece.

Strong Upward Pre-Market Activity For ISIS Pharmaceuticals (ISIS)

Should Isis Pharmaceuticals (ISIS) Be On Your Radar Now? - Tale of the Tape

Isis Pharmaceuticals Inc. Investors Can Finally Sense a Bright Future

After decades of zero return, Isis Pharmaceuticals' stock has been on fire recently. Is it smart to jump on board now?

Commit To Purchase Isis Pharmaceuticals At $33, Earn 9.1% Using Options

Isis Pharmaceuticals Up on Spinal Muscular Atrophy Data - Analyst Blog

ISIS Pharma Still Undervalued, Needham Says

IWM, CRBN: Big ETF Inflows

Health Care Sector Update for 06/22/2015: PFE, ISIS, KPTI

Amgen, Regeneron LDL-Lowering Drugs Provide Major Upside Potential To Their Stocks

See More ISIS News...

ISIS's Top Competitors

ISIS $56.13 (-1.80%)
Current stock: ISIS
AMGN $153.26 (-1.12%)
Current stock: AMGN
GILD $115.04 (-0.84%)
Current stock: GILD
BIIB $404.28 (-0.28%)
Current stock: BIIB